Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma
Conditions: Thyroid Cancer; Surgery; Recurrence Interventions: Drug: Thyroxine Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Academies | Cancer | Cancer & Oncology | Carcinoma | China Health | Hospitals | Research | Thyroid | Thyroid Cancer